[Federal Register Volume 80, Number 103 (Friday, May 29, 2015)]
[Notices]
[Page 30689]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-12977]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2014-N-1081]
Agency Information Collection Activities; Announcement of Office
of Management and Budget Approval; Guidance for Industry on
Postmarketing Adverse Event Reporting for Medical Products and Dietary
Supplements During an Influenza Pandemic
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
collection of information entitled, ``Guidance for Industry on
Postmarketing Adverse Event Reporting for Medical Products and Dietary
Supplements During an Influenza Pandemic'' has been approved by the
Office of Management and Budget (OMB) under the Paperwork Reduction Act
of 1995.
FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations,
Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver
Spring, MD 20993-0002, [email protected].
SUPPLEMENTARY INFORMATION: On January 8, 2015, the Agency submitted a
proposed collection of information entitled, ``Guidance for Industry on
Postmarketing Adverse Event Reporting for Medical Products and Dietary
Supplements During an Influenza Pandemic'' to OMB for review and
clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor,
and a person is not required to respond to, a collection of information
unless it displays a currently valid OMB control number. OMB has now
approved the information collection and has assigned OMB control number
0910-0701. The approval expires on April 30, 2018. A copy of the
supporting statement for this information collection is available on
the Internet at http://www.reginfo.gov/public/do/PRAMain.
Dated: May 22, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-12977 Filed 5-28-15; 8:45 am]
BILLING CODE 4164-01-P